Article thumbnail

Refolding by High Pressure of a Toxin Containing Seven Disulfide Bonds: Bothropstoxin-1 from Bothrops jararacussu

By Keli N. Balduino, Patrick J. Spencer, Natalia V. Malavasi, Rosa M. Chura-Chambi, Laura S. Lemke and Ligia Morganti


Aggregation is a serious obstacle for recovery of biologically active heterologous proteins from inclusion bodies (IBs) produced by recombinant bacteria. E. coli transformed with a vector containing the cDNA for Bothropstoxin-1 (BthTx-1) expressed the recombinant product as IBs. In order to obtain the native toxin, insoluble and aggregated protein was refolded using high hydrostatic pressure (HHP). IBs were dissolved and refolded (2 kbar, 16 h), and the effects of protein concentration, as well as changes in ratio and concentration of oxido-shuffling reagents, guanidine hydrochloride (GdnHCl), and pH in the refolding buffer, were assayed. A 32% yield (7.6 mg per liter of bacterial culture) in refolding of the native BthTx-1 was obtained using optimal conditions of the refolding buffer (Tris–HCl buffer, pH 7.5, containing 3 mM of a 2:3 ratio of GSH/GSSG, and 1 M GdnHCl). Scanning electron microscopy (SEM) showed that that disaggregation of part of IBs particles occurred upon compression and that the morphology of the remaining IBs, spherical particles, was not substantially altered. Dose-dependent cytotoxic activity of high-pressure refolded BthTx-1 was shown in C2C12 muscle cells

Topics: Research
Publisher: Humana Press Inc
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1999). An aromatic, but not a basic, residue is involved in the toxicity of group-II phospholipase A(2) neurotoxins.
  2. (1993). Bothropstoxin-I—amino-acid-sequence and function.
  3. (1992). Characterization and molecular-cloning of neurotoxic phospholipasesMol Biotechnol
  4. (1999). Comparative study of the cytolytic activity of myotoxic phospholipases A(2) on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro.
  5. (1993). Crystallization and preliminary diffraction data of two myotoxins isolated from the venoms of Bothrops asper (Terciopelo) and Bothrops nummifer (jumping viper).
  6. (1998). Crystallographic and spectroscopic characterization of a molecular hinge: Conformational changes in bothropstoxin I, a dimeric Lys49 phospholipase A2 homologue.
  7. (1988). Detection of myotoxin alpha-like proteins in various snake venoms.
  8. (2005). Differential susceptibility of C2C12 myoblasts and myotubes to group II phospholipase A2 myotoxins from crotalid snake venoms.
  9. (2004). Effect of a recombinant Lys49PLA2 myotoxin and Lys49PLA2-derived synthetic peptides from Agkistrodon species on membrane permeability to water.
  10. (2006). Effects of solutes on solubilization and refolding of proteins from inclusion bodies with high hydrostatic pressure.
  11. (2006). Folding aggregated proteins into functionally active forms.
  12. (2003). Functional expression and characterization of a recombinant phospholipase A2 from sea snake Lapemis hardwickii as a soluble protein in E.
  13. (1999). High pressure fosters protein refolding from aggregates at high concentrations.
  14. (2001). High pressure refolding of recombinant human growth hormone from insoluble aggregates. Structural transformations, kinetic barriers, and energetics.
  15. (2004). High-pressure refolding of bikunin: Efficacy and thermodynamics.
  16. (2002). Highpressure refolding of disulfide-cross-linked lysozyme aggregates: Thermodynamics and optimization.
  17. (1995). Hydrostatic and osmotic pressure as tools to study macromolecular recognition.
  18. (1999). Hydrostatic pressure rescues native protein from aggregates.
  19. (2007). Localization of functional polypeptides in bacterial inclusion bodies.
  20. (1998). Lys49 phospholipase A(2) myotoxins lyse cell cultures by two distinct mechanisms.
  21. (2008). Mapping the structural determinants of presynaptic neurotoxicity of snake venom phospholipases A(2).
  22. (2004). Maximizing recovery of native protein from aggregates by optimizing pressure treatment.
  23. (2000). Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Protein Expression and Purification,
  24. (2008). Permeabilization of E. coli K12 inner and outer membranes by bothropstoxin-I, A LYS49 phospholipase A2 from Bothrops jararacussu.
  25. (1995). Phospholipase a(2), myotoxins from bothrops snake-venoms.
  26. (2002). Preparative protein refolding.
  27. (1993). Pressure stability of proteins.
  28. (1981). Pressure-induced reversible dissociation of enolase.
  29. (2005). Reconstitution of functional nuclear receptor proteins using high pressure refolding. Molecular Genetics and
  30. (2001). Refolding and purification of Bothropstoxin-I, a Lys49-phospholipase A2 homologue, expressed as inclusion bodies
  31. (2008). Refolding of endostatin from inclusion bodies using high hydrostatic pressure.
  32. (1998). Refolding of recombinant proteins.
  33. (2004). Role of arginine in protein refolding, solubilization, and purification.
  34. (2005). Solubilization and refolding of bacterial inclusion body proteins.
  35. (2006). Structural analysis of protein inclusion bodies by Fourier transform infrared microspectroscopy.
  36. (1996). The use of hydrostatic pressure as a tool to study viruses and other macromolecular assemblages.